Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Tian-Kang Guo
Xiang-Yong Hao
Bin Ma
Ke-Hu Yang
Yi-Ping Li
Hong-Ling Li
Yuan-Hui Gu
Hui Cai
Ya-Li Liu
Yuan Li
Wei-Peng Zhan
机构：
[1] The People’s Hospital of Gansu Province,
[2] Evidence-Based Medicine Center of Lanzhou University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷
关键词：
Hepatocellular carcinoma; Octreotide; Liver disease; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1685 / 1692
页数：7
相关论文
共 50 条
  • [1] Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Guo, Tian-Kang
    Hao, Xiang-Yong
    Ma, Bin
    Yang, Ke-Hu
    Li, Yi-Ping
    Li, Hong-Ling
    Gu, Yuan-Hui
    Cai, Hui
    Liu, Ya-Li
    Li, Yuan
    Zhan, Wei-Peng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (12) : 1685 - 1692
  • [2] Efficacy of treatment regimens for advanced hepatocellular carcinoma A network meta-analysis of randomized controlled trials
    Chen, Qi-Feng
    Wu, Pei-Hong
    Huang, Tao
    Shen, Lu-Jun
    Huang, Zi-Lin
    Li, Wang
    MEDICINE, 2019, 98 (40)
  • [3] An Updated Meta-Analysis of Randomized Controlled Trials Assessing the Effect of Sorafenib in Advanced Hepatocellular Carcinoma
    Peng, Songlin
    Zhao, Yang
    Xu, Feng
    Jia, Changjun
    Xu, Yongqing
    Dai, Chaoliu
    PLOS ONE, 2014, 9 (12):
  • [4] Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials
    Ji, Xi-Qing
    Ruan, Xin-Jian
    Chen, Hong
    Chen, Gang
    Li, Shi-Yong
    Yu, Bo
    MEDICAL SCIENCE MONITOR, 2011, 17 (08): : RA169 - RA176
  • [5] Transarterial chemoembolization for unresectable hepatocellular carcinoma:: Meta-analysis of randomized controlled trials
    Cammà, C
    Schepis, F
    Orlando, A
    Albanese, M
    Shahied, L
    Trevisani, F
    Andreone, P
    Craxì, A
    Cottone, M
    RADIOLOGY, 2002, 224 (01) : 47 - 54
  • [6] Octreotide for improving survival in patients with advanced hepatocellular carcinoma: a meta-analysis
    Estanislao, N. I.
    Ang, E.
    Flores, H.
    Salvana, A.
    Tripon, E.
    Velasquez, M. E.
    Ong, J. P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A155 - A155
  • [7] Chemotherapy for advanced biliary tract carcinoma A meta-analysis of randomized controlled trials
    Chen, Lawrence
    Chen, Chiehfeng
    Yen, Yun
    Tam, Ka-Wai
    MEDICINE, 2016, 95 (33)
  • [8] Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials
    Zhang, Tao
    Ding, Xin
    Wei, Dong
    Cheng, Peng
    Su, Xiaomei
    Liu, Huanyi
    Wang, Daoyuan
    Gao, Hui
    ANTI-CANCER DRUGS, 2010, 21 (03) : 326 - 332
  • [9] Current Treatments for Small Hepatocellular Carcinoma: A Network Meta-Analysis of Randomized Controlled Trials
    Guo, Z.
    Zheng, Z.
    He, X.
    Chen, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 213 - 213
  • [10] Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
    Yue Han
    Wei-Hua Zhi
    Fei Xu
    Chen-Bo Zhang
    Xiao-Qian Huang
    Jian-Feng Luo
    World Journal of Gastroenterology, 2021, 27 (19) : 2415 - 2433
12345